Beta blockers and weight gain
Pro Research Analysisby 
Searched over 200M research papers
Beta Blockers and Weight Gain: Overview and Key Findings
Beta blockers are commonly prescribed for conditions like hypertension and heart failure, but several studies have shown a consistent association between beta blocker use and weight gain in various populations Sharma2001Pischon2001Av1990+3 MORE.
Weight Gain Magnitude and Patterns with Beta Blockers
Multiple clinical trials and observational studies report that beta blockers are linked to mild-to-moderate weight gain, typically in the range of 1 to 2 kg, though some studies suggest it can be higher, especially with long-term use Sharma2001Pischon2001Av1990+1 MORE. The weight gain often occurs in the first few months of treatment, with little additional gain over time Sharma2001Pischon2001. This effect is seen across different age groups, including older adults and postmenopausal women Coats2020Dzien2003Leung2020+1 MORE.
Mechanisms Behind Beta Blocker-Related Weight Gain
Beta blockers may cause weight gain by reducing metabolic rate and thermogenesis, leading to lower energy expenditure Pischon2001Av1990. They can decrease metabolic rate by about 10% and reduce facultative thermogenesis by 50-100 kcal per day, which can add up to several kilograms per year if not offset by dietary or activity changes Pischon2001Av1990. Additionally, beta blockers may worsen insulin resistance, which can further contribute to weight gain and complicate diabetes management .
Beta Blockers, Obesity, and Hypertension
Studies in both Western and Asian populations show that beta blocker use is associated with a higher prevalence of obesity, particularly among those with hypertension Coats2020Leung2020. In elderly Chinese populations, atenolol (a specific beta blocker) was especially linked to higher rates of obesity compared to other beta blockers or no beta blocker use Coats2020Leung2020. Some guidelines have even recommended beta blockers for obese hypertensive patients, but these findings raise questions about that practice Coats2020Pischon2001Leung2020.
Beta Blockers in Heart Failure and Diabetes
In patients with chronic heart failure, beta blocker therapy is associated with weight gain, especially in those with less severe symptoms and no fluid retention Boxall2012Sze2018. In these patients, weight gain may actually be a positive sign, as weight loss (cachexia) is linked to worse outcomes . Among patients with type 2 diabetes and hypertension, different beta blockers have varying effects: metoprolol is associated with more weight gain than carvedilol, especially in obese individuals .
Comparison with Other Antihypertensive Medications
Beta blockers tend to cause more weight gain than other antihypertensive drugs like ACE inhibitors, which may even have more favorable effects on body weight and insulin sensitivity . This difference is most pronounced in middle-aged patients, with the effect lessening in older age groups .
Clinical Implications and Recommendations
The consistent association between beta blocker use and weight gain suggests that clinicians should carefully consider the choice of antihypertensive therapy, especially in overweight or obese patients Sharma2001Pischon2001Leung2020+1 MORE. Weight gain can make obesity management more difficult and may worsen metabolic health, particularly in those already at risk for diabetes or cardiovascular disease Sharma2001Pischon2001Av1990+1 MORE. In some cases, alternative medications or careful monitoring may be warranted.
Conclusion
Beta blockers are associated with mild-to-moderate weight gain in a variety of patient groups, likely due to their effects on metabolism and energy expenditure. This side effect is important to consider, especially in patients who are already overweight or have metabolic risk factors. Clinicians should weigh the benefits and risks of beta blocker therapy and consider alternative treatments when appropriate.
Sources and full results
Most relevant research papers on this topic